Expression of glucose transporter 1 in human breast carcinoma and its clinical significance

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 1, 2009, Pages 44-47

  Hao, Lang Song ^a   Ni, Qing ^a   Jia, Gui Qing ^a   Wang, Geng ^a   Qian, Kun ^a   Liu, Yan Jun ^a   Zhang, Yi ^a   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Breast carcinoma; Glucose transporter 1 (glutl); Tumor cell proliferation

Indexed keywords

CYCLINE; GLUCOSE TRANSPORTER 1; SLC2A1 PROTEIN, HUMAN;

BREAST TUMOR; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 59449095587     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hoskin PJ, Sibtain A, Daley FM, et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of AR-CON. Br J Cancer, 2003; 89(7): 1290-1297.
2. Merrall NW, Plevin R, Gould GW. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal, 1993; 5(6): 667-675.
3. Grover-McKay M, Walsh SA, Seftor EA, et al. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res, 1998; 4(2): 115-120.
4. Stackhouse BL, Williams H, Berry P, et al. Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Tr,2005; 93(3): 247-253.
5. Zamora-Leon SP, Golde DW, Concha II, et al. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA, 1996; 93(5): 1847-1852.
6. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer,2004; 4(ll): 891-899.
7. Stubbs M, Bashford CL, Griffiths JR. Understanding the tumor metabolic phenotype in the genomic era. Curr Mol Med, 2003;3(1): 49-59.
8. Maria L, Mached A, Suzanne R, et al. Molecular and cellular regulation of glucose tranporter(GLUT) protein in cnacer. J Cell Physiol, 2005; 202(3): 654-662.
9. Rivenzon-Segal D, Boldin-Adamsky S, Seger D, et al. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer, 2003; 107(2): 177-182.
10. Bos R, van Der Hoeven JJ, van Der Wall E, et al. Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol, 2002; 20(2): 379-387.
11. Ito S, Fukusato T, Nemoto T, et al. Coexpression of glucose tranporter 1 and matrix metalloproteinase-2 in human cancers. J Natl Cancer Inst,2002; 94(14): 1080-1091.
12. Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. JPN J Cancer Res, 2002; 93(10): 1123-1128.